News & Trends - Medical Technology

TGA pushes for fee increases despite MedTech opposition

Health Industry Hub | July 1, 2020 |
[Total: 1    Average: 4/5]

MedTech News: The Therapeutic Goods Administration (TGA) is set to increase its fees by 1.95% in its 2020-2021 financial year.

The TGA decided on the fee increase tied to consumer price and wage inflation, despite a consultation revealing opposition from the MedTech industry.
 
In January 2020, TGA held a consultation to gather industry feedback on three options for changing its fees and charges. TGA stated its preferred option was a 1.95% increase, in line with an indexation factor tied to indices of consumer prices and wages. The agency also discussed maintaining its 2019-2020 fee structure or increasing its rates by 4.3%.

Around half of the responses to the consultation supported TGA’s preferred option. One medicine industry body noted it would have supported a 1.95% increase if not for the financial impact of COVID-19 on its members.

Stronger opposition came from the MedTech sector, where two industry bodies opposed any fee rises “due to the increasing cost of doing business and inability to pass such costs to their customers to remain competitive in the market.”
 
The Assistive Technology Suppliers Australia (ATSA) was among the opposition. “In percentage terms the proposed increases, in part due to the $10 rounding factor, is well above any [consumer price index] growth. Despite the impact of the $10 rounding approach from previous years that is compounding, annual increases have been continually applied. Only a monopoly situation can get away with such increases,” ATSA wrote in its feedback.
 
Other MedTech groups took a different position. The Medical Technology Association of Australia (MTAA) voiced support for raising fees by 1.95%, while also stating “it is important to also recognise that increases on fees and charges for medical device sponsors come on top of an industry already being punished under fairly dramatic price cuts by the same Government through the cuts in the Prostheses List.”


About the author

About the author

Lorem ipsum dolor sit amet, consectetur adipiscing elit. Nam luctus finibus scelerisque. Nunc bibendum ipsum sed augue fringilla fringilla. Nullam at consectetur leo. Praesent viverra rutrum porta. Quisque vitae mi vel purus vulputate tincidunt. Class aptent taciti sociosqu ad litora torquent per conubia nostra, per inceptos himenaeos. Suspendisse et mi quis nisi rhoncus feugiat at ac tellus. Sed aliquam sodales nulla ac auctor. Sed pretium lobortis purus accumsan ullamcorper. Phasellus sodales vel odio in lobortis. Duis maximus sagittis bibendum. Interdum et malesuada fames ac ante ipsum primis in faucibus. Nunc dictum tincidunt ipsum in vestibulum. Donec ut sem consectetur, aliquam quam vitae, pharetra orci. Nam egestas non velit eu rhoncus. Duis congue neque non lacus tincidunt porta. Vestibulum ultricies pulvinar sem, molestie congue dui aliquet non.
  • Ut imperdiet leo id lorem fermentum consectetur.
  • Ut vitae orci et dui varius tincidunt.
  • Ut id magna non libero vestibulum pharetra ac faucibus nulla.
Aliquam erat volutpat. Vestibulum vitae varius diam. Nulla eget congue ante. Nunc ullamcorper sagittis augue vel dictum. Mauris finibus nibh ut pulvinar auctor. Vestibulum ut faucibus nisi. Orci varius natoque penatibus et magnis dis parturient montes, nascetur ridiculus mus. Quisque porta tortor ac justo malesuada elementum. Nulla tellus ante, cursus nec ex sit amet, suscipit bibendum arcu. Duis posuere orci dui, et mollis enim dictum at. Sed ullamcorper, sapien ut vulputate viverra, sem purus porttitor tellus, nec mattis mauris ligula sed risus. Nulla sagittis id ipsum eu mattis. Link to full profile

News & Trends - Medical Technology

MedTech News - Private health insurer looking to invest in Australian private hospitals

Private health insurer looking to invest in Australian private hospitals

Health Industry Hub | July 15, 2020 |

MedTech News: In a recent opinion piece Dr Bill Coote, former AMA Secretary General and former Director of the Medicare […]

More


News & Trends - Pharmaceuticals

Pharma News - Merck Australia supports the first Australian-developed COVID-19 vaccine - Sypharma and Vaxine

Merck Australia supports the first Australian-developed COVID-19 vaccine

Health Industry Hub | July 15, 2020 |

Pharma News: Sypharma, an Australian biopharmaceutical formulation company, announced manufacturing of COVAX-19 and Advax adjuvant for Covid-19 in partnership with […]

More


News & Trends - Pharmaceuticals

Pharma News - Precision prescribing to combat Australia’s expected surge in mental illness

Precision prescribing to combat Australia’s expected surge in mental illness

Health Industry Hub | July 15, 2020 |

Pharma News: COVID-19 social isolation, familial and community disconnection, shock, job loss and health fears create the perfect storm for […]

More


Medical

Medical Pharma Biotech MedTech - $47M accelerator program for MedTech, Biotech and Pharma sectors in diabetes and cardiovascular disease

$47M accelerator program for MedTech, Biotech and Pharma sectors in diabetes and cardiovascular disease

Health Industry Hub | July 15, 2020 |

Medical News: The operation of the Australian Government’s $47 million Targeted Translation Research Accelerator (TTRA) initiative for diabetes and cardiovascular […]

More